Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Fluorometholone (FML) 0.1% eyedrops topically applied 4 times a day for 22 days
is more efficient than artificial tears (Liquifilm) in dry eye disease (DED) and ameliorates
the worsening of the disease after exposure to an adverse controlled environment.
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA